Market Overview

Rigel Pharmaceuticals, Inc. (NASDAQ: RIGL)

2.40 +0.13 (5.73%)

Analyst Ratings

DateResearch FirmActionCurrentPT
8/27/18CitigroupInitiates Coverage OnBuy8.5
5/02/18BMO CapitalMaintainsOutperform10.0
5/02/18H.C. WainwrightMaintainsBuy7.5
4/18/18BMO CapitalMaintainsOutperform8.0
4/03/18H.C. WainwrightMaintainsBuy6.7
12/15/17Cantor FitzgeraldInitiates Coverage OnOverweight6.0
11/06/17H.C. WainwrightAssumesBuy7.0
9/16/16JefferiesMaintainsBuy9.0
8/31/16BMO CapitalMaintainsOutperform6.0
8/01/16BMO CapitalInitiates Coverage onOutperform

Data powered by Benzinga Pro Calendars - Start your FREE TRIAL today!

Sign up to receive Benzinga's Daily Ratings Newsletter